Maravai LifeSciences Announces May and June 2024 Investor Conference Schedule
Rhea-AI Summary
Maravai LifeSciences, Inc. (NASDAQ: MRVI) announces its participation in investor conferences in May and June 2024. CEO Trey Martin and CFO Kevin Herde will engage in fireside chats at the RBC Healthcare Conference and Goldman Sachs Healthcare Conference, providing a live webcast for interested parties.
Positive
Maravai LifeSciences showcasing its presence and engagement in investor conferences indicates transparency and openness towards investors.
Live webcasts of the presentations offer accessibility to a wider audience, increasing transparency and investor relations.
Negative
- None.
News Market Reaction – MRVI
On the day this news was published, MRVI gained 6.09%, reflecting a notable positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
SAN DIEGO, May 09, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the months of May and June.
On May 15, 2024, at 3:15 p.m. EST, Trey Martin, Chief Executive Officer and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the RBC Healthcare Conference in New York City, NY.
On June 11, 2024, at 1:20 p.m. EST, Trey Martin, Chief Executive Officer and Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Goldman Sachs Healthcare Conference in Miami Beach, FL.
A live webcast of each presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, Upcoming events. An archived version of the webcast will also be available on the Maravai website after the event is completed.
About Maravai
Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.
For more information about Maravai LifeSciences, visit www.maravai.com.
FAQ
When will Maravai LifeSciences participate in investor conferences in May and June 2024?
What conferences will Maravai LifeSciences attend in May and June 2024?
Where can interested parties access the live webcasts of Maravai LifeSciences' presentations?
